Kerala Ayurveda Ltd
₹0.00▲ +0.00 (+0.00%)
KERALAAYURVEDALTD·NSE·Healthcare
Market Cap
228.66 Cr
PE Ratio
-8.70
Volume
—
Day High - Low
—
52W High-Low
503.90 - 145.00
₹0.00▲ +0.00 (+0.00%)
Market Cap228.66 Cr
PE Ratio-8.70
Volume—
Day High - Low—
52W High-Low503.90 - 145.00
Kerala Ayurveda Ltd (KERALAAYURVEDALTD): company summary
Kerala Ayurveda Ltd (KERALAAYURVEDALTD) is a micro-cap Healthcare company valued at ₹229 crore operating in Pharmaceuticals on the NSE and BSE.
Kerala Ayurveda Ltd (KERALAAYURVEDALTD) is a micro-cap Healthcare company valued at ₹229 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 12.1% a year over three years. Return on equity is -161.0%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 20.10 times book value.
- Things to watch
- Debt is 7.82 times equity.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
0.0/10
Poor
Fair Value
Sign in to see
ROE
-161.00%
Weak
P/E
-8.70x
Loss-making
Debt / Equity
7.82
High
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
52W₹145.00
₹503.90
DocStoX take
Supported by growth (7.3), but held back by risk (0.0). Scored on 4 of 5 measures.
DocStoX score
Low confidence0.0
/10
Poor
Quality
Weak
ROE -161.0%
Valuation
Expensive
P/B 20.1× on assets (no earnings to value)
Growth
Steady
Revenue +16.1% 5Y CAGR
Risk
High risk
D/E 7.82
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹229 Cr
52W High / Low
₹504 / ₹145
Dividend Yield
0.00%
Promoter Holding
35.61%
EPS (TTM)
₹-12.74
Book Value
₹8.56
Key highlights
- Revenue compounding 16% a year
- Loss-making — no meaningful P/E
- High leverage — debt is 7.8× equity
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Kerala Ayurveda Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Kerala Ayurveda Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Kerala Ayurveda Ltd with peers
Kerala Ayurveda Ltd vs Sun Pharmaceutical Industries LimitedKerala Ayurveda Ltd vs Divi's Laboratories LimitedKerala Ayurveda Ltd vs Torrent Pharmaceuticals LimitedKerala Ayurveda Ltd vs Apollo Hospitals Enterprise LimitedKerala Ayurveda Ltd vs Zydus Lifesciences LimitedKerala Ayurveda Ltd vs Laurus Labs Limited
Related tools & concepts
Value Kerala Ayurveda Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing